Beijing, China · Founded 2015 · In IPO Registration
Provider of gene sequencing and detection services intended for hospitals, research institutions, and pharmaceutical companies. Geneplus Technology is based in Beijing, China and was founded in 2015. Its last reported valuation was $605 million in Nov 2025. It has raised $186 million.
Last reported valuation
$604.6M
Oct 2026
Priced at
—
Total raised
$186.1M
Last round
—
Cap table — not yet on record
Geneplus Technology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Geneplus Technology with a free account
·The complete investor list: 27 names
·Watch Geneplus Technology: the Monday email on marks, rounds and moves
